{
  "main_header": {
    "sid": 142337,
    "name": "Krebs Biochem",
    "stock_name": "Krebs Biochem",
    "full_name": "Krebs Biochemicals & Industries Ltd",
    "name_url": "stocks-analysis/krebs-biochem",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "58.00",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "58.00",
    "mcapval": "125.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524518,
    "symbol": "KREBSBIO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE268B01013",
    "curr_date": "Feb 02",
    "curr_time": "",
    "bse_nse_vol": "803 ",
    "exc_status": "Active",
    "traded_date": "Feb 02, 2026",
    "traded_date_str": "2026 02 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/krebs-biochem-142337-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Krebs Biochem falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-krebs-biochem-fallingrising-3693428",
        "imagepath": "",
        "date": "2025-11-12 22:09:28",
        "description": "As of 12-Nov, Krebs Biochemicals & Industries Ltd is experiencing a decline in its stock price, currently at Rs 66.89, which reflects a decrease of Rs 3.05 or 4.36%. The stock has underperformed significantly today, with a performance that is 5.34% lower than its sector. It opened with a loss of 2.77% and reached an intraday low of Rs 66.89. Additionally, the stock is trading below all key moving averages, indicating a bearish trend. Over the past week, the stock has fallen by 5.51%, and its year-to-date performance shows a substantial decline of 27.69%. Notably, investor participation has dropped sharply, with delivery volume plummeting by 92.31% compared to the five-day average, suggesting a lack of confidence among investors.\n\nIn the broader market context, Krebs Biochem's performance contrasts sharply with the Sensex, which has gained 1.21% over the past week and 8.10% year-to-date. This divergence indi..."
      },
      {
        "title": "Krebs Biochemicals Declines 1.53% Amid Notable Buying Trend Despite Year-to-Date Drop of 28.81%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/krebs-biochemicals-declines-153-amid-notable-buying-trend-despite-year-to-date-drop-of-2881-3688860",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/KrebsBiochemica_only_buyers_3688860.png",
        "date": "2025-11-11 09:45:15",
        "description": "Krebs Biochemicals & Industries Ltd is experiencing notable buying activity amid a downward trend in its stock performance. Despite recent declines and significant long-term challenges, market participants appear to be exploring opportunities in this microcap stock within the pharmaceuticals and biotechnology sector."
      }
    ],
    "total": 111,
    "sid": "142337",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/krebs-biochemicals-industries-142337"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Board Meeting Intimation To Consider And Adopt The Unaudited Financial Results For The 3Rd Quarter And Nine Months Ended December 31 2025",
      "datetime": "14-Jan-2026",
      "details": "Krebs Biochemicals & Industries Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve Board Meeting intimation to consider and adopt the unaudited financial results for the 3rd quarter and nine months ended December 31 2025",
      "source": "BSE"
    },
    {
      "caption": "Report On Re-Lodgement Of Transfer Requests Of Physical Shares Dec 2025",
      "datetime": "05-Jan-2026",
      "details": "The Company has enclosed herewith report on relodgement of shares for the month of December 2025.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "02-Jan-2026",
      "details": "The Company has enclosing herewith certificate recived from RTA under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 31.12.2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Krebs Biochemicals & Industries Ltd has announced <strong>21:100</strong> rights issue, ex-date: 31 Jan 19",
          "dt": "2019-01-31",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Why is Krebs Biochem falling/rising?

2025-11-12 22:09:28

As of 12-Nov, Krebs Biochemicals & Industries Ltd is experiencing a decline in its stock price, currently at Rs 66.89, which reflects a decrease of Rs 3.05 or 4.36%. The stock has underperformed significantly today, with a performance that is 5.34% lower than its sector. It opened with a loss of 2.77% and reached an intraday low of Rs 66.89. Additionally, the stock is trading below all key moving averages, indicating a bearish trend. Over the past week, the stock has fallen by 5.51%, and its year-to-date performance shows a substantial decline of 27.69%. Notably, investor participation has dropped sharply, with delivery volume plummeting by 92.31% compared to the five-day average, suggesting a lack of confidence among investors. In the broader market context, Krebs Biochem's performance contrasts sharply with the Sensex, which has gained 1.21% over the past week and 8.10% year-to-date. This divergence indi...

Read More

Krebs Biochemicals Declines 1.53% Amid Notable Buying Trend Despite Year-to-Date Drop of 28.81%

2025-11-11 09:45:15

Krebs Biochemicals & Industries Ltd is experiencing notable buying activity amid a downward trend in its stock performance. Despite recent declines and significant long-term challenges, market participants appear to be exploring opportunities in this microcap stock within the pharmaceuticals and biotechnology sector.

Read More

View All News